Safety, tolerability and effect on pentagastrin-stimulated gastric acid output (PSAO) of the new reversible proton pump inhibitor BY841: B. Simon, P. Müller, M. Hartmann∗, R. Huber∗, H. Bliesath∗, R. Lühmann∗, W. Wurst∗, H.W. Radtke∗. Clinic Schwetzingen, Salem Clinic, Heidelberg and ∗Byk Gulden Pharmaceuticals, Konstanz, Germany

• Book ID: 118879559
• Publisher: Elsevier Science
• Year: 1995
• Tongue: English
• Weight: 147 KB
• Volume: 108
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/0016-5085(95)23541-8